Ferring Pharmaceuticals Announces Return of STIMATE
Ferring Pharmaceuticals Announces Return of STIMATE
The product is expected to return to market in October of 2026
On June 1st, 2026, the federal Centers for Medicare and Medicaid Services (CMS) released its long-awaited rule providing guidance to state Medicaid programs on how to implement the Medicaid work reporting requirements and eligibility limits